Cross-talk Between the Unfolded Protein Response and Nuclear Factor-κB Signalling Pathways Regulates Cytokine-mediated Beta Cell Death in MIN6 Cells and Isolated Mouse Islets
Overview
Authors
Affiliations
Aims/hypothesis: Pancreatic beta cell destruction in type 1 diabetes may be mediated by cytokines such as IL-1β, IFN-γ and TNF-α. Endoplasmic reticulum (ER) stress and nuclear factor-κB (NFκB) signalling are activated by cytokines, but their significance in beta cells remains unclear. Here, we investigated the role of cytokine-induced ER stress and NFκB signalling in beta cell destruction.
Methods: Isolated mouse islets and MIN6 beta cells were incubated with IL-1β, IFN-γ and TNF-α. The chemical chaperone 4-phenylbutyric acid (PBA) was used to inhibit ER stress. Protein production and gene expression were assessed by western blot and real-time RT-PCR.
Results: We found in beta cells that inhibition of cytokine-induced ER stress with PBA unexpectedly potentiated cell death and NFκB-regulated gene expression. These responses were dependent on NFκB activation and were associated with a prolonged decrease in the inhibitor of κB-α (IκBα) protein, resulting from increased IκBα protein degradation. Cytokine-mediated NFκB-regulated gene expression was also potentiated after pre-induction of ER stress with thapsigargin, but not tunicamycin. Both PBA and thapsigargin treatments led to preferential upregulation of ER degradation genes over ER-resident chaperones as part of the adaptive unfolded protein response (UPR). In contrast, tunicamycin activated a balanced adaptive UPR in association with the maintenance of Xbp1 splicing.
Conclusions/interpretation: These data suggest a novel mechanism by which cytokine-mediated ER stress interacts with NFκB signalling in beta cells, by regulating IκBα degradation. The cross-talk between the UPR and NFκB signalling pathways may be important in the regulation of cytokine-mediated beta cell death.
Bhowmick D, Ahn M, Bhattacharya S, Aslamy A, Thurmond D Metabolism. 2025; 164:156132.
PMID: 39805534 PMC: 11798586. DOI: 10.1016/j.metabol.2025.156132.
Yu Y, Wang M, Chen R, Sun X, Sun G, Sun X J Ginseng Res. 2021; 45(6):642-653.
PMID: 34764719 PMC: 8569261. DOI: 10.1016/j.jgr.2019.09.003.
Mooranian A, Ionescu C, Wagle S, Kovacevic B, Walker D, Jones M Pharmaceutics. 2021; 13(10).
PMID: 34684006 PMC: 8538409. DOI: 10.3390/pharmaceutics13101713.
Molecular Machinery and Pathophysiology of Mitochondrial Dynamics.
Chiu Y, Lin S, Kuo C, Li C Front Cell Dev Biol. 2021; 9:743892.
PMID: 34604240 PMC: 8484900. DOI: 10.3389/fcell.2021.743892.
Javeed N, Her T, Brown M, Vanderboom P, Rakshit K, Egan A Cell Rep. 2021; 36(8):109613.
PMID: 34433033 PMC: 8420815. DOI: 10.1016/j.celrep.2021.109613.